Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bird

Showing results (761-770 of 813) with videos related to

Pageof 82
Sort By:
Nature Medicine|July 11, 2025
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trialJörg F Hipp, Carlos A Bacino, Lynne M Bird, et al.
Nature Medicine|August 5, 2025
Ultraprocessed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomized, crossover trialSamuel J Dicken, Friedrich C Jassil, Adrian Brown, et al.
Clinical Proteomics|January 9, 2019
Identification of <i>Cytauxzoon felis</i> antigens via protein microarray and assessment of expression library immunization against cytauxzoonosisMegan E Schreeg, Henry S Marr, Jaime L Tarigo, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Angelman syndrome: Mutations influence features in early childhoodWen-Hann Tan, Carlos A Bacino, Steven A Skinner, et al.
Human Genetics|November 10, 2001
Scanning for telomeric deletions and duplications and uniparental disomy using genetic markers in 120 children with malformationsM J Rosenberg, C Killoran, L Dziadzio, et al.
Obesity (Silver Spring, Md.)|November 3, 2023
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label studyJennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
American Journal of Medical Genetics. Part A|February 6, 2019
Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutationsKatheryn Grand, Christina Gonzalez-Gandolfi, Amanda M Ackermann, et al.
American Journal of Medical Genetics. Part A|May 29, 2021
Syndromic neurodevelopmental disorder associated with de novo variants in DDX23William Burns, Lynne M Bird, Delphine Heron, et al.
British Journal of Haematology|February 8, 2019
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trialGordon Cook, Kara-Louise Royle, Sheila O'Connor, et al.
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Pageof 82

Showing results (761-770 of 813) with videos related to

Sort By:
Pageof 82
Nature Medicine|July 11, 2025
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trialJörg F Hipp, Carlos A Bacino, Lynne M Bird, et al.
Nature Medicine|August 5, 2025
Ultraprocessed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomized, crossover trialSamuel J Dicken, Friedrich C Jassil, Adrian Brown, et al.
Clinical Proteomics|January 9, 2019
Identification of <i>Cytauxzoon felis</i> antigens via protein microarray and assessment of expression library immunization against cytauxzoonosisMegan E Schreeg, Henry S Marr, Jaime L Tarigo, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Angelman syndrome: Mutations influence features in early childhoodWen-Hann Tan, Carlos A Bacino, Steven A Skinner, et al.
Human Genetics|November 10, 2001
Scanning for telomeric deletions and duplications and uniparental disomy using genetic markers in 120 children with malformationsM J Rosenberg, C Killoran, L Dziadzio, et al.
Obesity (Silver Spring, Md.)|November 3, 2023
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label studyJennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
American Journal of Medical Genetics. Part A|February 6, 2019
Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutationsKatheryn Grand, Christina Gonzalez-Gandolfi, Amanda M Ackermann, et al.
American Journal of Medical Genetics. Part A|May 29, 2021
Syndromic neurodevelopmental disorder associated with de novo variants in DDX23William Burns, Lynne M Bird, Delphine Heron, et al.
British Journal of Haematology|February 8, 2019
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trialGordon Cook, Kara-Louise Royle, Sheila O'Connor, et al.
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Pageof 82